Cerus Corporation (NASDAQ:CERS) changes shares on Thursday trading session, with a change of -0.99% or -$0.07 shares. The trading starts at $7.07 and closed at $7.07 throughout the day. The trading session low price was $6.82 and day high was $7.13 on Thursday, July 09. After the session, the Healthcare sector daily volume shifted to 1.5 million while its average volume is 2.02M. In other hand, the CERS market cap reached to $1.15B. While, its current target price is $8.50.
On July 7, 2020, BRIEF-Cerus Corp Reports Successful Inactivation Of Sars-Cov-2 With The Intercept Blood System For Plasma. According to the news reported on Reuters, * CERUS CORPORATION REPORTS SUCCESSFUL INACTIVATION OF SARS-COV-2 WITH THE INTERCEPT BLOOD SYSTEM FOR PLASMA
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 3.55% and up 20.07% for month. Its quarterly performance was 39.72% above, while its half year performance is up 54.87%. CERS yearly performance stood at positive 28.91% and rise 65.88% for year-to-date. Current recommendation for Cerus Corporation is 1.50.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. CERS EPS (TTM) for 12-month is -0.48. EPS for this year is -16.50%, while for the next year its value is -0.35. Its EPS Q/Q reached 23.70%. It has an EPS of 0.30% up for past five years.
Let’s take a look on the analyst recommendations on CERS for the current month and previous month. For the current month, 4 of 4 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $6.50-$9.50. Average target price for CERS was reached at $8.50.
ARK Investment Management, LLC, Baker Brothers Advisors, LLC and Blackrock Inc. are the top three holders in Cerus Corporation (CERS) stock. On Mar 30, 2020, ARK Investment Management, LLC has 14.01 million shares which valued 65.12 million. On Mar 30, 2020, Baker Brothers Advisors, LLC owned 13.71 million shares which valued at 63.77 million. On Mar 30, 2020, Blackrock Inc. has a total of 12.5 million shares which valued at 58.14 million. In the end, Blackrock Inc. have 7.62% shares outstanding of Cerus Corporation (CERS) on Mar 30, 2020. The insider ownership moved to 2.20% and institutional holding shifted to 75.70%.
The company posted an EPS (TTM) of -0.48. According to the most recent quarter report on (Jun 2020), 4 analysts estimated an average EPS of -0.11, while -0.13 EPS posted a year ago period. Analyst Estimated EPS for CERS published in the report was -0.12–0.1 during the same period. Comparing with last year, the average estimated EPS was -0.13 which is lower than -0.1 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for CERS rise 42.49% for period of 200 days. SMA for 50 days was 15.40% which is showing green signal, while SMA-20 was 6.82%. The moving average value for Cerus Corporation (CERS) is 5.18 and 6.37 for 200 and 50 days respectively.
Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in CERS stock. On Jul 07, Benjamin Richard J, Chief Medical Officer, sold 154,583 trading shares at the cost of $7.20, which valued at 1.11 million. On Jun 25, Moore Carol, SVP Reg. & Quality, sold 130,000 shares at the cost of $7.00, with total shares of 111,751. On Jun 01, Moore Carol, SVP Reg. & Quality, sold 30,025 shares at the cost of 6.50. After this transaction, Moore Carol total shares reached to 111,751 which valued at 0.2 million.